Press Releases

LAKE FOREST, Calif., Oct. 31, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, is proud to announce that it has received Health Canada Certification for multiple new products which will further expand its penetration into the Canadian market. Included in this certification are Morpheu

SARASOTA, Fla., Oct. 31, 2019 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of the FDA cleared INVOcell®, the world's only in vivo Intravaginal Culture System, is pleased to share an open letter to shareholders written by its

TAMPA, Fla., Oct. 31, 2019 /PRNewswire/ -- INHIBITOR Therapeutics, Inc. (OTCQB: INTI), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics to inhibit the progression of cancerous and non-cancerous proliferation disorders, today announced that Debra Peattie, PhD, MBA has b

BOSTON, Oct. 31, 2019 /PRNewswire/ -- The VHL Alliance (VHLA) today announced the 2019 recipients of the VHLA Competitive Research Grant Program.  This year, three grantees were chosen.  Scientists are increasingly aware that curing von Hippel-Lindau disease, a genetic form of cancer – is a key step to curing cancer, leading to a significant increase in t

GAITHERSBURG, Md., Oct. 31, 2019 /PRNewswire/ -- The Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA) granted Shreis Scalene Sciences (Shreis), in Gaithersburg, MD, 'Breakthrough Device Designation' for the CYTOTRON® - a CE marked, whole-body therapeutic medical device. "We are confident

NORTH CHICAGO, Ill., Oct. 31, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced positive top-line data from the SELECT-PsA 2 Phase 3 study. In this study, both doses of RINVOQ™ (upadacitinib; 15 mg and 30 mg, once daily) met the primary endpoint of ACR20 response at week 12 versus placebo in adult pati

VANCOUVER, British Columbia, Oct. 31, 2019 /PRNewswire/ -- Clarius Mobile Health launched its second-generation series of wireless ultrasound scanners today, putting the power and im

FAYETTEVILLE, N.C., Oct. 31, 2019  /PRNewswire/ -- Debbie's Dream Foundation: Curing Stomach Cancer (DDF) will host the 6th Annual Fayetteville, North Carolina Golf Tournament & Charity Dinner on Nov 2, 2019, at Gates Four Golf & Country Club. The tournament, which will begin at

PROVIDENCE, R.I., Oct. 31, 2019 /PRNewswire/ -- It's no secret that becoming a doctor takes years of schooling and training. However, even after becoming a licensed medical professional, the education and certification process never ends. Maintenance of Certification (MOC) and Continuing Medical Education (CME) are often complicated and expensive processes requiring medi

NEW YORK, Oct. 31, 2019 /PRNewswire/ -- The US Navy Veterans Mesothelioma Advocate says, "Our top priority is making certain a US Navy Veteran with confirmed mesothel